P+P United is dedicated to the following principles
Protect Your Access to Cancer Care and Complex Therapies—Support H.R. 4299
When you’re fighting cancer or another complex chronic disease, the last thing you should worry about is losing your doctor or the treatment plan you trust. But recent changes in Medicare drug pricing under the Inflation Reduction Act could put your access to care at risk, especially for patients who rely on local clinics and infusion centers.
Why This Matters. What This Means.
Medicare’s new rules that will go int effect in 2028 aim to lower drug costs, but they also reduce what clinics are paid for certain complex therapies. Community clinics use those payments to cover the cost of the medicine itself, specialized staff, and the safe environment needed for infusion and specialized treatment.
These cuts will have a devastating impact. A 2025 report by Milliman estimates that oncology clinics face a $26 billion reduction; neurology practices a $17 billion shortfall and rheumatology nearly $3 billion in loss. Across all medical specialties, the impact is expected to be over $56 billion. Forcing clinics to absorb these cuts pushes many into financial instability. If reimbursement falls below what it costs to provide quality complex medical care, community-based clinics simply can’t sustain these services.
When that happens, patients are forced to switch medical providers, travel to large hospitals (often far from home) and establish a new care routine. This leads to:
- Longer travel times for every appointment.
- Delays in starting, continuing, or adjusting treatment.
- Added stress and expense for families already facing a serious illness.
This isn’t about profit; it’s about keeping care local and accessible. H.R. 4299 fixes this by ensuring clinics can stay open while still lowering your out-of-pocket costs for complex therapies.
H.R. 4299 is the Fix
The Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299) ensures seniors save on drug costs without sacrificing care. It keeps treatment close to home, lowers out-of-pocket costs, and protects individualized care plans.
This bill ensures:
- Your care stays close, in your community. Clinics can keep their doors open by maintaining fair reimbursement for selected Medicare Part B drugs.
- Lower costs for you. Coinsurance is based on the lower Medicare Fair Price (MFP), so you pay less for life-saving treatments.
- Savings without harm. Instead of cutting payments to your doctor, the bill requires manufacturers to provide drug rebates directly to Medicare. Patients and clinical care teams are not pawns in a tug-of-war.
- Protection for personalized treatment. Your doctor can prescribe the right therapy, in the right setting, at the right time.
Your voice matters! Join patients, providers, and caregivers in telling Congress, “Protect my access to care”. Support H.R. 4299 today.”